logo negro baker tilly
Contacto

m&a biotecnológico

m&a biotecnológico

Te acompañamos en cada paso
Array ( [0] => WP_Term Object ( [term_id] => 153 [name] => global corporate finance [slug] => global-corporate-finance [term_group] => 0 [term_taxonomy_id] => 153 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 624 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 790 [name] => m&a biotecnológico [slug] => ma-biotecnologico [term_group] => 0 [term_taxonomy_id] => 790 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 334 [name] => M&A españa [slug] => ma-espana [term_group] => 0 [term_taxonomy_id] => 334 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 147 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 791 [name] => werfenlife [slug] => werfenlife [term_group] => 0 [term_taxonomy_id] => 791 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) )
La española WerfenLife adquiere la estadounidense Accriva Diagnostics por $380M para reforzar su división de Diagnóstico in Vitro.
WerfenLife, el gigante médico catalán  que factura €1.175M anuales quiere potenciar su división de diagnostico in [...]
seguir leyendo >>
crossmenuchevron-down